Page 4 of 9
< 1 2 3 4 5 6 7 8 9  >
  • Diabetology

    New NICE guidance increases insulin options for some people with diabetes

    NICE has issued guidance to the NHS in England and Wales on the use of inhaled insulin for the treatment of diabetes (type 1 and 2). NICE has recommended inhaled insulin for some people with type 1 or 2 diabetes who have either a severe needle phobia or serious ongoing problems with injection sites, making injections very difficult.

    National Institute for Health and Clinical Excellence - Wed, 13 December 2006
    http://www.nice.org.uk

  • Dietetics and Nutrition

    Obesity and maintaining a healthy weight

    NICE has issued the first ever national guideline addressing both the prevention and treatment of obesity in adults and children. It contains wide ranging recommendations, not just for the NHS, but also for schools and early years providers, local authorities, employers and town planners. The guideline also sets out what individuals can do to help maintain a healthy weight.

    National Institute for Health and Clinical Excellence - Wed, 13 December 2006
    http://www.nice.org.uk

  • Infectious Diseases

    Pneumococcal Disease in Latin America Kills Two Children Every Hour, New Study Finds

    Global health experts today released the most comprehensive study ever conducted on the impact of pneumococcal disease in South America and the Caribbean, and revealed potential health and economic benefits of a vaccine already routinely given to children in the United States.

    The Pan American Health Organization - Wed, 13 December 2006
    http://www.paho.org/

  • Infectious Diseases

    Statement on Kenyan and Ugandan trial findings regarding male circumcision and HIV

    The Joint United Nations Programme on HIV/AIDS and its Cosponsors, WHO, UNFPA, UNICEF and the World Bank, note with considerable interest today’s announcement by the US National Institutes of Health that two trials assessing the impact of male circumcision on HIV risk are being stopped on the recommendation of the NIH Data Safety and Monitoring Board (DSMB).

    World Health Organization - Wed, 13 December 2006
    http://www.who.int

  • Infectious Diseases

    New vaccines against cervical cancer major opportunity for developing world

    The introduction of new vaccines against Human Papillomavirus (HPV), the virus that causes cervical cancer, could have a major impact on the health of women in the developing world. More than 250 000 women died from cervical cancer in 2005 - the vast majority in developing countries.

    World Health Organization - Wed, 13 December 2006
    http://www.who.int

  • Infectious Diseases

    The Ethics and Politics of Compulsory HPV Vaccination

    On September 12, 2006, 3 months after the Food and Drug Administration licensed a vaccine against human papillomavirus (HPV), Michigan lawmakers became the first in the United States to propose that vaccination be compulsory for girls entering sixth grade.

    New England Journal of Medicine - Wed, 13 December 2006
    http://www.nejm.org

  • Cardiology

    Coronary Intervention for Persistent Occlusion after Myocardial Infarction

    In the Occluded Artery Trial (OAT), 2166 patients who had myocardial infarction with ST-segment elevation 3 to 28 days before enrollment and an occluded infarct-related coronary artery were randomly assigned to percutaneous coronary intervention (PCI) or medical therapy.

    New England Journal of Medicine - Wed, 13 December 2006
    http://www.nejm.org

  • Oncology

    Five-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid Leukemia

    The constitutively active BCR-ABL tyrosine kinase is the cause of chronic myeloid leukemia. Imatinib is the first small synthetic molecular inhibitor of the BCR-ABL tyrosine kinase with clinical activity in chronic-phase myeloid leukemia. This 5-year follow-up of patients with the disease who began continuous treatment with imatinib reports that the drug can induce durable hematologic and cytogenetic responses in a high proportion of patients.

    New England Journal of Medicine - Wed, 13 December 2006
    http://www.nejm.org

  • Coloproctology

    Klebsiella oxytoca as a Causative Organism of Antibiotic-Associated Hemorrhagic Colitis

    In this study, six patients received a diagnosis of antibiotic-associated hemorrhagic colitis and were negative for Clostridium difficile; five were positive for K. oxytoca. In a rat model, treatment with amoxicillin-clavulanate plus inoculation with K. oxytoca resulted in hemorrhagic colitis, showing that K. oxytoca can cause antibiotic-associated hemorrhagic colitis.

    New England Journal of Medicine - Wed, 13 December 2006
    http://www.nejm.org

  • Infectious Diseases

    Mad cow disease: Still a concern

    Although stricter regulations have reduced the number of cases, mad cow disease hasn't gone away. Stay informed about the disease and its risks.

    MayoClinic.com - Wed, 13 December 2006
    http://www.mayoclinic.com

< 1 2 3 4 5 6 7 8 9  >
Page 4 of 9